Suneel Gupta

Insider Reports History

Location
Newark, CA
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Suneel Gupta
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Suneel Gupta:

Company Role Class Num Shares Value Price $ Report Date Ownership
Protagonist Therapeutics, Inc Chief Development Officer Common Stock 267,433 $3,254,660 $12.17 26 Nov 2024 Direct
Protagonist Therapeutics, Inc Chief Development Officer Stock Option (right to buy) 93,300 26 Nov 2024 Direct

Insider Reports Filed by Suneel Gupta

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PTGX Protagonist Therapeutics, Inc 25 Nov 2024 12 -$3,908,853 4 Chief Development Officer 27 Nov 2024, 19:09
PTGX Protagonist Therapeutics, Inc 26 Feb 2024 1 -$126,447 4 Chief Development Officer 28 Feb 2024, 20:00
PTGX Protagonist Therapeutics, Inc 09 Jan 2024 3 -$88,100 4 Chief Development Officer 11 Jan 2024, 20:00
PTGX Protagonist Therapeutics, Inc 02 Jan 2024 2 $0 4 Chief Development Officer 04 Jan 2024, 20:15
PTGX Protagonist Therapeutics, Inc 19 Oct 2023 2 +$147,600 4 Chief Development Officer 23 Oct 2023, 16:31
PTGX Protagonist Therapeutics, Inc 31 May 2023 2 -$108,190 4 Chief Development Officer 02 Jun 2023, 19:51
PTGX Protagonist Therapeutics, Inc 16 Jan 2023 2 $0 4 Chief Development Officer 18 Jan 2023, 18:56
PTGX Protagonist Therapeutics, Inc 26 Apr 2022 2 +$295,200 4 Chief Development Officer 26 Apr 2022, 21:42
PTGX Protagonist Therapeutics, Inc 28 Feb 2022 1 -$15,758 4 Chief Development Officer 02 Mar 2022, 19:40
PTGX Protagonist Therapeutics, Inc 15 Feb 2022 2 $0 4 Chief Development Officer 17 Feb 2022, 18:24